In Bordeaux, the CHU on Wednesday launched the first outpatient clinical trial for anyone over 65 through four treatments.
- An outpatient study for treatments against Covid-19 has been launched at the Bordeaux University Hospital
- 4 treatments will be tested on nearly 1,000 people
- Results are expected in May 2020
France continues to be on the front line against the coronavirus. The Bordeaux University Hospital launched the world’s first outpatient clinical trial on Wednesday April 15, according to Yann Bubien, director of the Bordeaux hospital. On an outpatient basis, this means medical treatment without hospitalization or for a short period. This takes place in the Albert Thomas gymnasium, an annex to the Chaban-Delmas stadium, transformed into a mini-hospital where doctors, interns, externs, pharmacists, nurses, administrative staff, etc. meet.
Regular and permanent follow-up
The goal of this trial is to treat the disease as early as possible. This allows “avoid any deterioration and keep patients on an outpatient basisbelieves Professor Denis Malvy, member of the scientific council, to 20 minutes. We are going to test four treatments, three of which are new, on nearly 1,000 people. The study will continue as long as the epidemic is there and we have not found an effective drug. Here will be our base.”
This study focuses on people over the age of 65 who are Covid-19 positive and volunteer to participate in the test. Named Coverage, the study will adapt the treatment according to the patient who will be given a monitoring kit with blood pressure monitor or an electrocardiograph. “This person will be followed very closely with three visits in the first ten days.specifies Alexandre Duvignaud, infectiologist. Either from his attending physician or from ourselves. There will also be regular phone calls and he should, if possible, use the Rafaël platform set up by the CHU or send us information by email or telephone on his state of health..”
No results for a month
The four treatments used to treat participants are an antihypertensive, an antiviral and hydroxychloroquine, developed by Professor Raoult. This care with these treatments will be done within three days of a positive result for the Covid-19 test. The first results of the study are not for now, doctors preferring to remain cautious. “We’re not going to start setting dates like with the Discovery study. But you will have to wait at least a month anyway.“, according to Alexandre Duvignaud. In the meantime, hospitals in the north and east of France have already approached the Bordeaux University Hospital to set up the same system and participate in the Coverage study.
.